| Literature DB >> 30135772 |
Christian Aljoscha Lukas1, Matthias Berking1.
Abstract
BACKGROUND: Procrastination affects a large number of individuals and is associated with significant mental health problems. Despite the deleterious consequences individuals afflicted with procrastination have to bear, there is a surprising paucity of well-researched treatments for procrastination. To fill this gap, this study evaluated the efficacy of an easy-to-use smartphone-based treatment for procrastination.Entities:
Keywords: Intervention; Mobile health; Procrastination; Smartphone; Treatment
Year: 2017 PMID: 30135772 PMCID: PMC6096330 DOI: 10.1016/j.invent.2017.07.002
Source DB: PubMed Journal: Internet Interv ISSN: 2214-7829
Fig. 1CONSORT flow diagram.
Sample characteristics.
| Treatment group ( | Control group ( | Test statistic | ||
|---|---|---|---|---|
| Age | 21.63 (3.56) | 22.47 (3.78) | .528 | |
| Gender | 12 (75) | 14 (93.3) | Fisher’s exact test | .333 |
| Education | ||||
| High school | 13 (81.25) | 14 (93.33) | Fisher's exact test | .600 |
| University degree | 3 (18.75) | 1 (6.67) | ||
| Occupation | ||||
| Student | 14 (87.50) | 15 (100) | Fisher's exact test | .484 |
| Other | 2 (12.50) | 0 (0) | ||
| Standard period of study | ||||
| Surpassed | 1 (18.75) | 4 (26.67) | Fisher's exact test | .330 |
| Not surpassed | 13 (81.25) | 11 (73.33) |
Fig. 2Path model.
ANOVAS and repeated-measures-ANOVAs.
| n | t1 | t2 | t3 | Between group ANOVA | Repeated-measures ANOVA | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| t1 | t2 (after 2 weeks) | t3 (after 6 weeks) | Measurement-point | Group-membership*measurement-point | Group-membership | |||||||||||
| F (1,29) | η2 (95%-CI) | F (df) | η2 (95%-CI) | F (df) | η2 (95%-CI) | F (df) | η2 (95%-CI) | F (df) | η2 (95%-CI) | F (df) | η2 (95%-CI) | |||||
| APROF | 0.16 | .01 (.00–.15) | 2.98 (1,25) | .11 (.00–.34) | 5.14 (1,25) | .17 (.00–.41) | 8.15 (1.45, 34.80) | .25 (.04–.45) | 4.11 (1.50, 34,80) | .01 (.00–.08) | 1.75 (1,24) | .05 (.00–.30) | ||||
| INT | 12 | 5.44 (0.65) | 4.92 (0.75) | 4.46 (0.89) | ||||||||||||
| CTR | 14 | 5.28 (0.49) | 5.33 (0.57) | 5.10 (0.76) | ||||||||||||
| APSI | 1.03 | .03 (.00–.22) | 3.81 (1,25) | .13 (.00–.37) | 3.09 (1,25) | .1 (.00–.34) | 6.83 (1.53, 36.79) | .22 (.02–.41) | 6.28 (1.50, 40.40) | .19 (.03–.34) | 1.95 (1,24) | .08 (.00–.30) | ||||
| INT | 12 | 3.29 (0.42) | 2.80 (0.54) | 2.72 (0.47) | ||||||||||||
| CTR | 14 | 3.18 (0.59) | 3.25 (0.53) | 3.12 (0.57) | ||||||||||||
t-Tests.
| Change t1–t2 | Change t2–t3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| APROF | Intervention | 14 | 3.95 | 13 | 0.75 (0.41–1.15) | 14 | 1.52 | 13 | 0.59 (0.20–1.06) |
| Control | 13 | − 0.53 | 12 | − 0.14 (− 0.40–0.16) | 12 | 1.86 | 11 | 0.36 (0.04–0.79) | |
p < .05.
p < .01.